Global Women’s Health Diagnostics Market Size, Share, Development and Demand Forecast to 2022
Explore report at: www.psmarketresearch.com/market-analysis/womens-health-diagnostics-market
The rapid growth in emerging economies with increasing number of diagnostic and imaging centers and increasing adoption of point-of-care diagnostic testing drives the growth of the market. However, high cost of diagnostic imaging systems and procedures, and shortage of skilled laboratory technicians are the key restraints hampering the growth of the global market.
Request For Table of Content at: www.psmarketresearch.com/market-analysis/womens-health-diagnostics-market/toc-sample
As per the United Nations Department of Economic and Social Affairs (UN-DESA) report on the global aging population, the population of people aged 60 years or above is growing with high rate. In 2013, the global share of people aged 60 or above was 11.7% and it is expected to reach 21.1% by the end of 2050. Further, the number of people aged 60 years and above is expected to reach approximately 437 million in China, 324 million in India, 107 million in the U.S. and 58 million in Brazil by 2050. The increase in geriatric pool supports the market growth as aged people have weakened body functions, impaired blood circulation and are more susceptible to chronic diseases.
Browse Other Related Report at: www.psmarketresearch.com/industry-report/medical-devices
The key players operating in the global women’s health diagnostic market are F. Hoffmann-LA Roche AG, Siemens AG, Hologic, Inc., Quest Diagnostics Inc., Alere Inc., Perkinelmer, Inc., GE Healthcare, Koninklijke Philips N.V., Abbott Laboratories, Becton, Dickinson and Company and Biomérieux SA.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Women’s Health Diagnostics Market Size, Share, Development and Demand Forecast to 2022 here
News-ID: 470859 • Views: 289
More Releases from P&S Market Research- Medical Devices
Increasing Aging Population Drives Global Vascular Imaging Systems Market
The global vascular imaging systems market is expected to grow at a CAGR of 5.7%, during 2017 - 2023. Increasing healthcare expenditure drives the global market According to the study, the global vascular imaging systems market is likely to grow significantly, during the forecast period, due to increasing healthcare expenditure, increasing prevalence of cancer and cardiovascular diseases and rising awareness about imaging techniques due to various conferences and seminars. In addition, growing
North America Emerges as Largest Nuclear Imaging Equipment Market
The global nuclear imaging equipment market is expected to grow at a CAGR of 4.8%, during 2017 - 2023. Increasing geriatric population drives the global market According to the study, the global nuclear imaging equipment market is likely to grow significantly during the forecast period, due to rising prevalence of cancer and cardiovascular diseases, increasing geriatric population and increasing prevalence of neurological disorders. In addition, rising healthcare expenditure and launch of technologically
North America Emerges as Largest Nerve Repair and Regeneration Market
The global nerve repair and regeneration market is expected to grow at a CAGR of 11.9% during 2017 - 2023. Increasing geriatric population drives the global market According to the study, the global nerve repair and regeneration market is likely to grow significantly during the forecast period, due to increasing geriatric population, rising prevalence of chronic pain and increasing incidence of neurological disorders. In addition, the awareness about mental diseases and their
Global Phototherapy Equipment Market Analysis, Size, Share, Development and Dema …
The global phototherapy equipment market is witnessing considerable growth due to the increasing incidence of neonatal jaundice and increasing prevalence of skin problems including psoriasis, eczema and vitiligo. Moreover, the increasing adoption of LED-based phototherapy equipment and launch of technologically advanced products are further supporting the growth of the market. Among the various equipment types, the conventional phototherapy equipment segment lead the market in terms of size. The phototherapy equipment
More Releases for Diagnostics
Transplant Diagnostics Market
Transplant diagnostics is the examination of factors associated with recently performed transplant. This can be elaborated as safety testing, compatibility, testing, transplant feasibility testing, pre, peri, and post transplantation. This is done to check the tissue compatibility between the donor and patient in organ transplant. Major Players: The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA,
Demand for Rapid Diagnostics Tests Trending the Pneumonia Diagnostics Market
The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report
Europe Transplant Diagnostics Market
The Europe Transplant Diagnostics Market Report is an upcoming report from Data Bridge Market Research. The new market report contains data for historic years 2015, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Transplant diagnostics are the diagnostics tests performed while relocating organ in order to treat organ failure such as liver, pancreas, lungs, kidney, and heart. These tests are widely performed by skilled
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about
Global Influenza Diagnostics Market 2017 : BioMerieux, SA Scientific, Enigma Dia …
Influenza Diagnostics Market 2017 A market study based on the " Influenza Diagnostics Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Influenza Diagnostics Market 2017’. The research report analyses the historical as well as present performance of the worldwide Influenza Diagnostics industry, and makes predictions on the future status of Influenza Diagnostics market on the basis of this analysis. Get Free Sample Copy of
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test